Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Nanoparticle tumor accumulation relies on a key mechanism, the enhanced permeability and retention (EPR) effect, but it remains challenging to decipher the exact impact of the EPR effect. Animal models in combination with imaging modalities are useful, but it is impossible to delineate the roles of multiple biological barriers involved in nanoparticle tumor accumulation. Here we report a microfluidic tumor-vasculature-on-a-chip (TVOC) mimicking two key biological barriers, namely, tumor leaky vasculature and 3D tumor tissue with dense extracellular matrix (ECM), to study nanoparticle extravasation through leaky vasculature and the following accumulation in tumor tissues. Intact 3D tumor vasculature was developed with selective permeability of small molecules (20 kDa) but not large ones (70 kDa). The permeability was further tuned by cytokine stimulation, demonstrating the independent control of the leaky tumor vasculature. Combined with tumor spheroids in dense ECM, our TVOC model is capable of predicting nanoparticles' in vivo tumor accumulation, thus providing a powerful platform for nanoparticle evaluation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Micro fl uidic studies using linear channels have also shown that use of coculture devices to screen NPs and determine optimal properties such as size, shape, and surface charge may be translated to in vivo tumor models 27”
From Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model (2019) · cites this paper as [27]
In the citing paper
“The microfluidic channel replicates an intact vascular structure surrounding the tumor that have a junction gap of ∼2 µm [48].”
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Fabrication of microfluidic systems in poly(dimethylsiloxane)
McDonald, J. C., Duffy, D. C., Anderson, J. R., Chiu, D. T., Wu, H., Schueller, O. J. A., & Whitesides, G. M. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000101)21:1<27::aid-elps27>3.0.co;2-c · Cited by 3,329
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Research works printed but not linked: 1
- Fox, 2006, Human Physiology, 501
Cited by
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
Development of High‐Drug‐Loading Nanoparticles
Liu, Y., Yang, G., Jin, S., Xu, L., & Zhao, C. (2020) · ChemPlusChem · doi:10.1002/cplu.202000496 · Cited by 410
Self-citationRole of Nanoparticle Mechanical Properties in Cancer Drug Delivery
Hui, Y., Yi, X., Hou, F., Wibowo, D., Zhang, F., Zhao, D., Gao, H., & Zhao, C.-X. (2019) · ACS Nano · doi:10.1021/acsnano.9b03924 · Cited by 388
Self-citationOrgan-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
“At present, tumor OoCs also include colorectal [55, 140], ovarian [141, 142], prostate [143, 144], bladder [145, 146], cervical [147, 148], gastric [56, 149], and skin [150, 151] cancer.”
BackgroundEndothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model
Haase, K., Offeddu, G. S., Gillrie, M. R., & Kamm, R. D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002444 · Cited by 127
Organ‐on‐a‐Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine
Rodrigues, R. O., Sousa, P. C., Gaspar, J., Bañobre‐López, M., Lima, R. A., & Minas, G. M. H. (2020) · Small · doi:10.1002/smll.202003517 · Cited by 144
Advancing engineering design strategies for targeted cancer nanomedicine
Gomerdinger, V. F., Nabar, N., & Hammond, P. T. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-025-00847-2 · Cited by 146
“…cells into tissue-like structures on microfluidic culture devices and can recapitulate vasculature fluid flow to study nanoparticle trafficking under flow conditions across the BBB 240,241 , through the endothelium 242,243 , in lymphatics and immune organs 244,245 , and into tumours 245,246 .”
Transvascular transport of nanocarriers for tumor delivery
Li, X., Hu, Y. M., Zhang, X., Shi, X., Parak, W. J., & Pich, A. (2024) · Nature Communications · doi:10.1038/s41467-024-52416-0 · Cited by 160
“Itis encouraging that the developed organ-on-chip models may simultaneously address these challenges, including preclinical models to recapitulate human biology and tumor heterogeneity,aswellashigh-throughputtesting 99,100 .”
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Heinrich, M. A., Mostafa, A. M. R. H., Morton, J. P., Hawinkels, L. J. A. C., & Prakash, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.018 · Cited by 126
Li, W., Zhou, Z., Zhou, X., Khoo, B. L., Gunawan, R., Chin, Y. R., Zhang, L., Yi, C., Guan, X., & Yang, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202609 · Cited by 119
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Chen, X., Zhang, Y. S., Zhang, X., & Liu, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.09.022 · Cited by 107
“For example, to mimic the tumor microenvironment and study nanoparticle extravasation through leaky tumor vasculature, Wang et al. linked a Vascular Chip in combination with a Cancer Chip [101].”
BackgroundMethodInfluentialSurendran, V., Rutledge, D., Colmon, R., & Chandrasekaran, A. (2021) · Biofabrication · doi:10.1088/1758-5090/abe1cf · Cited by 99
Advances of Microfluidics in Biomedical Engineering
Zhong, Q., Ding, H., Gao, B., He, Z., & Gu, Z. (2019) · Advanced Materials Technologies · doi:10.1002/admt.201800663 · Cited by 106
Organ-on-a-chip technology for nanoparticle research
Kang, S., Park, S. E., & Huh, D. (2021) · Nano Convergence · doi:10.1186/s40580-021-00270-x · Cited by 108
Zou, D., Wu, Z., Yi, X., Hui, Y., Yang, G., Liu, Y., Tengjisi, Wang, H., Brooks, A., Wang, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214757120 · Cited by 104
“First, to study the translocation of MCSNs through the tumor endothelial barrier, an impaired vasculature model was established by culturing human umbilical vein endothelial cells (HUVECs) on the membrane of a transwell insert, which was then treated with TNF-α (39, 40) to induce the damage of hepatic sinusoidal endot…”
InfluentialSelf-citationTumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Tian, C., Zheng, S., Liu, X., & Kamei, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01552-0 · Cited by 101
“Reproduced with permission [53], Copyright 2018,”
Backgroundde Carvalho, B. G., Ceccato, B. T., Michelon, M., Han, S. W., & de la Torre, L. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010141 · Cited by 103
Lim, J., Ching, H., Yoon, J., Jeon, N. L., & Kim, Y. (2021) · Nano Convergence · doi:10.1186/s40580-021-00261-y · Cited by 91
Mathematical and computational modeling of nano-engineered drug delivery systems
Shamsi, M., Mohammadi, A., Manshadi, M. K. D., & Sanati-Nezhad, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.014 · Cited by 79
Polysaccharide-based nanocarriers for efficient transvascular drug delivery
Zhang, M., Ma, H., Wang, X., Yu, B., Cong, H., & Shen, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.051 · Cited by 77
Nanotheranostics Targeting the Tumor Microenvironment
Roma‐Rodrigues, C., Pombo, I., Raposo, L. R., Pedrosa, P., Fernandes, A. R., & Baptista, P. V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00197 · Cited by 84
Multifunctional microfluidic chip for cancer diagnosis and treatment
Guo, Q., Zhang, L.-L., Liu, J., Li, Z., Li, J.-J., Zhou, W., Wang, H., Li, J., Liu, D., Yu, X., et al. (2020) · Nanotheranostics · doi:10.7150/ntno.49614 · Cited by 81
“The technical Tumor-Vasculature-on-a-Chip (TVOC) was reported to assessing NPs extravasation through leaky vasculature and their accumulation in tumor tissues, which provided a powerful platform for the preclinical evaluation on NPs [150].”
BackgroundSelf-citationCheng, F., Cao, X., Li, H., Liu, T., Xie, X., Huang, D., Maharjan, S., Bei, H., Gómez, A., Li, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00583 · Cited by 73
Emerging tumor-on-chips with electrochemical biosensors
Lei, L., Ma, B., Xu, C., & Liu, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116640 · Cited by 72
Joseph, M. M., Ramya, A. N., Vijayan, V. M., Nair, J. B., Bastian, B. T., Pillai, R. K., Therakathinal, S. T., & Maiti, K. K. (2020) · Small · doi:10.1002/smll.202003309 · Cited by 68
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Liu, X., Su, Q., Zhang, X., Yang, W., Ning, J., Jia, K., Xin, J., Li, H., Yu, L., Liao, Y., et al. (2022) · Biosensors · doi:10.3390/bios12111045 · Cited by 75
Ran, R., Wang, H., Hou, F., Liu, Y., Hui, Y., Petrovsky, N., Zhang, F., & Zhao, C. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900015 · Cited by 68
Self-citationGradient-sized control of tumor spheroids on a single chip
Fang, G., Lu, H., Law, A. M. K., Gallego‐Ortega, D., Jin, D., & Lin, G. (2019) · Lab on a Chip · doi:10.1039/c9lc00872a · Cited by 67
Lee, S., Kim, S., Koo, D.-J., Yu, J., Cho, H., Lee, H., Song, J. M., Kim, S., Min, D., & Jeon, N. L. (2020) · ACS Nano · doi:10.1021/acsnano.0c05110 · Cited by 68
Biofabrication Strategies and Engineered In Vitro Systems for Vascular Mechanobiology
Pradhan, S., Banda, O. A., Farino, C. J., Sperduto, J. L., Keller, K. A., Taitano, R. A., & Slater, J. H. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901255 · Cited by 64
Recent trends of biomaterials and biosensors for organ-on-chip platforms
Gonçalves, I. M., Rodrigues, R. O., Moita, A., Hori, T., Kaji, H., Lima, R. A., & Minas, G. M. H. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00202 · Cited by 66
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Engineered Biomimetic Membranes for Organ-on-a-Chip
Rahimnejad, M., Rasouli, F., Jahangiri, S., Ahmadi, S., Rabiee, N., Farani, M. R., Akhavan, O., Asadnia, M., Fatahi, Y., Hong, S., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00531 · Cited by 59
Evaluation of cancer immunotherapy using mini-tumor chips
Ao, Z., Cai, H., Wu, Z., Hu, L., Li, X., Kaurich, C., Gu, M., Cheng, L., Lu, X., & Guo, F. (2022) · Theranostics · doi:10.7150/thno.71761 · Cited by 52
“Additionally, modeling tumor vasculature and structure on-chip could also facilitate understanding the TME and develop immune-oncology therapies [39, 40].”
BackgroundRapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model
Vu, M. N., Rajasekhar, P., Poole, D. P., Khor, S. Y., Truong, N. P., Nowell, C. J., Quinn, J. F., Whittaker, M., Veldhuis, N. A., & Davis, T. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02056 · Cited by 52
3D bioprinted tumor model with extracellular matrix enhanced bioinks for nanoparticle evaluation
Chen, Y., Xu, L., Li, W., Chen, W., He, Q., Zhang, X., Tang, J., Wang, Y., Liu, B., & Liu, J. (2022) · Biofabrication · doi:10.1088/1758-5090/ac48e4 · Cited by 58
“The vasculature and the dense extracellular matrix (ECM) consisting of collagen and fibers represent the most two significant barriers to the delivery of NPs [10].”
InfluentialZhou, Q., Liu, Q., Wang, Y., Chen, J., Schmid, O., Rehberg, M., & Yang, L. (2024) · Advanced Science · doi:10.1002/advs.202308659 · Cited by 59
Tumor-Microenvironment-on-a-Chip for Evaluating Nanoparticle-Loaded Macrophages for Drug Delivery
Wang, H., Liu, Y., Wang, T., Yang, G., Zeng, B., & Zhao, C. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00650 · Cited by 57
Self-citationWu, S., Ye, Y., Zhang, Q., Kang, Q., Xu, Z., Ren, S., Lin, F., Duan, Y., Xu, H., Hu, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202203742 · Cited by 55
Dynamic screening and printing of single cells using a microfluidic chip with dual microvalves
Chen, C., Xu, D. L., Bai, S., Yu, Z., Zhu, Y., Xing, X. F., & Chen, H. (2020) · Lab on a Chip · doi:10.1039/d0lc00040j · Cited by 48
Zhang, Z., Yan, H., Li, S., Liu, Y., Ran, P., Chen, W., & Li, X. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127073 · Cited by 48
Self-citationCao, Z., Li, D., Wang, J., Xiong, M., & Yang, X. (2019) · Small · doi:10.1002/smll.201902022 · Cited by 46
The Role of in silico Research in Developing Nanoparticle-Based Therapeutics
Jayasinghe, M. K., Lee, C. Y., Tran, T., Tan, R., Chew, S. M., Yeo, B. Z. J., Loh, W. X., Pirisinu, M., & Le, M. T. N. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.838590 · Cited by 57
“(104) used a microfluidic Tumor-Vasculature-on-a-Chip, to investigate the influence of EPR effect on PEGylated and PEG-PLGA NP extravasation and selective accumulation in parts of tumors.”
MethodCancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
Gil, J. F., Moura, C. S., Silvério, V., Gonçalves, G., & Santos, H. A. (2023) · Advanced Materials · doi:10.1002/adma.202300692 · Cited by 48
Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)
Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43
Organ-on-chip systems as a model for nanomedicine
Stavrou, M., Phung, N. B., Grimm, J., & Andreou, C. (2023) · Nanoscale · doi:10.1039/d3nr01661g · Cited by 50
A microfluidic hanging drop-based spheroid co-culture platform for probing tumor angiogenesis
Rodoplu, D., Matahum, J., & Hsu, C. (2022) · Lab on a Chip · doi:10.1039/d1lc01177d · Cited by 48
Simpson, J. D., Smith, S. A., Thurecht, K. J., & Such, G. K. (2019) · Polymers · doi:10.3390/polym11091441 · Cited by 43
“Microfluidics offer one of the only means for mimicking vascular conditions and controlling specific factors such as flow rate experimentally [117,118].”
BackgroundDevelopment of Core‐Shell Nanoparticle Drug Delivery Systems Based on Biomimetic Mineralization
Yang, G., Liu, Y., Jin, S., & Zhao, C. (2020) · ChemBioChem · doi:10.1002/cbic.202000105 · Cited by 43
Self-citationCancer Metastasis‐on‐a‐Chip for Modeling Metastatic Cascade and Drug Screening
Brooks, A., Zhang, Y., Chen, J., & Zhao, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302436 · Cited by 44
Self-citationGuerrero‐López, P., Martín-Pardillos, A., Bonet‐Aleta, J., Mosseri, A., Hueso, J. L., Santamaría, J., & García‐Aznar, J. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-03504-8 · Cited by 51
“Many authors have reported the potential of microfluidic platforms to construct 3D tumor models that effectively mimic the architecture of the tumor microenvironment highlighting different aspects that in 2D models are missing such as tumor vascularization 47 , drug response 48 , nutrient and oxygen gradients 49 , co-…”
InfluentialOrgan-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
Haque, M. R., Rempert, T. H., Al-Hilal, T. A., Wang, C., Bhushan, A., & Bishehsari, F. (2021) · Cancers · doi:10.3390/cancers13174487 · Cited by 36
“The leaky tumor vasculature was shown to occur after co-culturing human ovarian cancer spheroid and endothelial cells within a dense matrix on a chip [53].”
BackgroundIn Vitro Models of Biological Barriers for Nanomedical Research
Carton, F., & Malatesta, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168910 · Cited by 34
Tang, Y., Tian, F., Miao, X., Wu, D., Wang, Y., Wang, H., You, K., Li, Q., Zhao, S., & Wang, W. (2022) · Biofabrication · doi:10.1088/1758-5090/ac975d · Cited by 39
“The fluorescent intensity was extracted using ZEN software, and the apparent permeability coefficient (Papp) could be calculated according to the following equation [30, 31]:”
Self-citationTian, Y., Cheng, T., Sun, F., Zhou, Y., Yuan, C., Guo, Z., & Wang, Z. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103124 · Cited by 41
Li, Z., Cheng, H., Wang, B., Wang, L., Wu, J., Zhang, B., Tang, Z., & Qu, S. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.04.153 · Cited by 37
Peng, X., Chen, K., Liu, W., Cao, X., Wang, M., Tao, J., Tian, Y., Bao, L., Lu, G., & Teng, Z. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00465-7 · Cited by 37
Real-Time Ratiometric Imaging of Micelles Assembly State in a Microfluidic Cancer-on-a-Chip
Feiner‐Gracia, N., Mares, A. G., Buzhor, M. G., Rodriguez-Trujíllo, R., Samitier, J., Amir, R. J., Pujals, S., & Albertazzi, L. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01209 · Cited by 34
Ahmed-Cox, A., Pandžić, E., Johnston, S. T., Heu, C., McGhee, J. B., Mansfeld, F. M., Crampin, E. J., Davis, T. P., Whan, R. M., & Kavallaris, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.014 · Cited by 39
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
“[63], Copyright 2018 American Chemical Society;”
Wu, Y., Zhou, Y., Qin, X., & Liu, Y. (2021) · Biomicrofluidics · doi:10.1063/5.0062697 · Cited by 37
Self-citationPerspectives on organ-on-a-chip technology for natural products evaluation
Wang, X., Miao, Y., Zhao, X.-M., Liu, X., Hu, Y.-W., & Deng, D. (2024) · Food & medicine homology. · doi:10.26599/fmh.2024.9420013 · Cited by 43
Cancer stem cells and strategies for targeted drug delivery
Cao, J., Bhatnagar, S., Wang, J., Qi, X., Prabha, S., & Panyam, J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00863-9 · Cited by 34
Emerging role and promise of nanomaterials in organoid research
Mahapatra, C., Lee, A., & Paul, M. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.007 · Cited by 31
Ifijen, I. H., Awoyemi, C. T., Lekan, O. K., Aworinde, O. R., Faderin, E., Oluwafunke, O., Akanji, T. F. A., Igboanugo, J. C., Udogu, U., Ogidi, G. O., et al. (2024) · RSC Advances · doi:10.1039/d4ra05732e · Cited by 32
Development of a Microfluidic Droplet-Based Microbioreactor for Microbial Cultivation
Ho, C. M. B., Sun, Q., Teo, A. J. T., Wibowo, D., Gao, Y., Zhou, J. W., Huang, Y., Tan, S. H., & Zhao, C. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00292 · Cited by 29
Self-citationTumor‐On‐A‐Chip Models for Predicting In Vivo Nanoparticle Behavior
de Roode, K. E., Hashemi, K., Verdurmen, W. P. R., & Brock, R. E. (2024) · Small · doi:10.1002/smll.202402311 · Cited by 34
Mallya, D., Gadre, M. A., Varadharajan, S., & Vasanthan, K. S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1457872 · Cited by 38
Li, Y., Sun, K., Shao, Y. C., Wang, C., Xue, F., Chu, C., Gu, Z., Chen, Z., & Bai, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402611 · Cited by 29
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy
Abaza, T., Mohamed, E., & Zaky, M. Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-02939-3 · Cited by 39
Liu, Z., Ran, H., Wang, Z., Zhou, S., & Wang, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s212888 · Cited by 27
“by nanoscale particle size.(28,29) Besides the passive targeting, efficient active accumulation and intracellular uptake were generated via the combination of integrin αvβ3, which is overexpressed on membranes of tumor cells and in neovascularization, with the specific ligand RGD peptide on DPP-R.”
BackgroundZou, H., Li, M., Li, X., Zheng, W., Kuang, H., Wang, M., Zhang, W., Ran, H., Ma, H., & Zhou, X. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2081379 · Cited by 30
“Due to its magnetic targeting and EPR effect, CMT NPs can easily be transported through blood vessels and accumulate in tumors, reducing drug hydrolysis and increasing drug concentration at the tumor site (Wu & Yang, 2017; Wang et al., 2018; Haimov-Talmoud et al., 2019).”
BackgroundRathod, S., Arya, S., Kanike, S., Shah, S. A., Bahadur, P., & Tiwari, S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122093 · Cited by 28
Barbato, M. G., Pereira, R. C., Mollica, H., Palange, A. L., Ferreira, M. F. M. M., & Decuzzi, P. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.03.053 · Cited by 31
Tackling Current Biomedical Challenges With Frontier Biofabrication and Organ-On-A-Chip Technologies
Celikkin, N., Presutti, D., Maiullari, F., Fornetti, E., Agarwal, T., Paradiso, A., Volpi, M., Święszkowski, W., Bearzi, C., Barbetta, A., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.732130 · Cited by 26
“…model with tumor leaky vasculature and 3D tumor tissue with dense ECM to study extravasation through leaky vasculature and accumulation Wang et al. (2018a) Development of built-in vasculature system for direct surgical anastomosis Zhang et al. (2016) (Continued on following…”
BackgroundMethodInfluentialMa, J., Zhang, J., Chi, L., Liu, C., Li, Y., & Tian, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.034 · Cited by 25
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
“Despite its complexity, recent advances have been made towards the development of perfusable vascularized networks in tumor-on-chip technology [30,50,51].”
BackgroundAdvances in microfluidic 3D cell culture for preclinical drug development
(2022) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2021.07.022 · Cited by 23
In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?
Salata, G. C., Hirokawa, C. M., de Melo, G. B., Malagó, I. D., Nunes, J. R., Passos, J. S., Daré, R. G., & Lopes, L. B. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00321-6 · Cited by 26
Biophysical properties of hydrogels for mimicking tumor extracellular matrix
Cameron, A. P., Zeng, B., Liu, Y., Wang, H., Soheilmoghaddam, M., Cooper-White, J. J., & Zhao, C. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212782 · Cited by 25
Self-citationYang, G., Liu, Y., Hui, Y., Tengjisi, Chen, D., Weitz, D. A., & Zhao, C. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101730 · Cited by 21
Self-citationRecent advances in lab-on-a-chip systems for breast cancer metastasis research
Yildirir, B. F., Yalcin-Ozuysal, Ö., & Nonappa, N. (2023) · Nanoscale Advances · doi:10.1039/d2na00823h · Cited by 33
Axons-on-a-chip for mimicking non-disruptive diffuse axonal injury underlying traumatic brain injury
Pan, X., Li, J., Li, W., Wang, H., Durisic, N., Li, Z., Feng, Y., Liu, Y., Zhao, C., & Wang, T. (2022) · Lab on a Chip · doi:10.1039/d2lc00730d · Cited by 22
Self-citationNanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 24
Bazban‐Shotorbani, S., Khare, H. A., Kajtez, J., Basak, S., Lee, J., & Kamaly, N. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00397 · Cited by 20
Li, J., Rong, R.-X., Yang, Y. H., Hu, Z., Hu, B., Zhao, Y., Li, H., Hu, X., Wang, K., & Guo, D. (2023) · Materials Horizons · doi:10.1039/d3mh00018d · Cited by 20
Imparato, G., Urciuolo, F., Mazio, C., & Netti, P. A. (2022) · Lab on a Chip · doi:10.1039/d2lc00611a · Cited by 20
Sood, A., Kumar, A., Gupta, V. K., Kim, C. M., & Han, S. S. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01080 · Cited by 22
Gimondi, S., Ferreira, H., Reis, R. L., & Neves, N. M. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c00481 · Cited by 20
Engineered Vasculature for Cancer Research and Regenerative Medicine
Nguyen, H. T., Peirsman, A., Tirpáková, Z., Mandal, K., Vanlauwe, F., Maity, S., Kawakita, S., Khorsandi, D., Herculano, R. D., Umemura, C., et al. (2023) · Micromachines · doi:10.3390/mi14050978 · Cited by 19
“reported a device to model the leaky vasculature of tumor tissues and study its eff cts on the p rfusion of th apeutic-sized nanoparticles (NPs) [92].”
BackgroundEngineering Heterogeneous Tumor Models for Biomedical Applications
Wu, Z., Huang, D., Wang, J., Zhao, Y., Sun, W., & Shen, X. (2023) · Advanced Science · doi:10.1002/advs.202304160 · Cited by 25
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
Abdelkarim, M., Pérez-Dávalos, L. A., Abdelkader, Y., Abostait, A., & Labouta, H. I. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2152000 · Cited by 20
Shie, M., Fang, H., Kan, K., Ho, C., Tu, C., Lee, P., Hsueh, P., Chen, C., Lee, A. K.-X., Tien, N., et al. (2023) · Advanced Science · doi:10.1002/advs.202206603 · Cited by 20
Cooley, M. B., Wulftange, W. J., Wegierak, D., Goreke, U., Abenojar, E., Gurkan, U. A., & Exner, A. A. (2023) · Lab on a Chip · doi:10.1039/d3lc00514c · Cited by 18
Bourn, M. D., Mohajerani, S. Z., Mavria, G., Ingram, N., Coletta, P. L., Evans, S. D., & Peyman, S. A. (2023) · Lab on a Chip · doi:10.1039/d2lc00963c · Cited by 20
On-microparticle construction of endothelialized liver microtissues for drug testing
Wu, Z., Zheng, Y., Lin, J., Li, Y., Li, Y., Wang, X., & Lin, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.148403 · Cited by 18
ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions
Ro, J., Kim, J., Park, J., Choi, Y., & Cho, Y. (2025) · Advanced Science · doi:10.1002/advs.202410659 · Cited by 21
Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities
Wang, J., Zhao, Y., & Nie, G. (2023) · Medical Review · doi:10.1515/mr-2023-0028 · Cited by 20
“Nonetheless, it has already been reported that vascular-on-chips could be used to mimic normal and tumor blood vessels, and to evaluate the extravasation ability of nanoparticles under di ff erent conditions [155, 156].”
Background
Metadata
- Authors
- Wang, H.-F., Ran, R., Liu, Y., Hui, Y., Zeng, B., Chen, D., Weitz, D. A., & Zhao, C.-X.
- Affiliations
- The University of Queensland , , , ,
- The University of Queensland (AU)
- State Key Laboratory Fluid Power and Mechatronic Systems (CN)
- Harvard University (US)
- Corresponding author
- Zhao, Chun-Xia
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-10-31
- Volume
- 12
- Issue
- 11
- Pages
- 11600-11609
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2899310002
- Semantic Scholar
- 8272278fc82b83ca8565e0af6d93c644e83995ed
- Cited by
- 161
- References
- 48
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 20 · 2023: 24 · 2022: 30 · 2021: 23 · 2020: 18 · 2019: 13
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Biomedical Imaging and Bioengineering (R01EB014703)
- Australian Research Council (FT140100726)
- Division of Materials Research (DMR-1420570, DMR-1708729)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- nanoparticle extravasation, tumor accumulation, enhanced permeability and retention effect, extracellular matrix, tumor spheroids, microfluidic model, nanoparticle drug delivery
- MeSH terms
- Animals, Extracellular Matrix, Female, Fluorescent Dyes, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasms, Tissue Distribution, Mice, Nanoparticles, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.